Group 1 - Emerald Wealth Partners' Growth Equity Strategy reported a Q4 2025 return of +3.1% (gross) and +3.0% (net), contributing to a year-to-date return of 16.7% (gross) and +16.0% (net) [1] - The strategy faced challenges in 2025, including concerns about a potential bubble in Artificial Intelligence (AI) markets and the impact of President Trump's trade and foreign policies [1] - Revvity, Inc. (NYSE:RVTY) was highlighted as a stock of interest, with a market capitalization of $9.924 billion, but it experienced a one-month return of -8.72% and a 52-week loss of 22.57% [2] Group 2 - The decision to exit the position in Revvity, Inc. was based on limited visibility into the company's business trajectory and management's failure to deliver on key strategic elements, leading to a reassessment of its risk-reward profile [3] - Revvity, Inc. was not included in the list of the 40 Most Popular Stocks Among Hedge Funds, although 35 hedge fund portfolios held the stock at the end of Q4 2025, an increase from 22 in the previous quarter [3] - The company is viewed as having potential, but certain AI stocks are considered to offer greater upside potential with less downside risk [3]

Group 1: Fund Performance - Bretton Fund returned 1.44% in Q4 2025 compared to 2.66% for the S&P 500 Index [1] - For the full year 2025, the Fund returned 11.58% versus 17.88% for the Index [1] - The firm views the overall market as modestly elevated but not in bubble territory [1] Group 2: Investment Strategy - The Fund is focusing on areas of value that will provide good returns over the long term [1] - The Fund is willing to reduce speculative elements of the AI boom, even if it leads to temporary lag during strong market phases [1] Group 3: Revvity, Inc. (NYSE:RVTY) Overview - Revvity, Inc. has a market capitalization of $11.166 billion [2] - The stock closed at $98.49 per share on March 04, 2026, with a one-month return of -1.03% and a 52-week loss of 13.00% [2] Group 4: Revvity, Inc. Investment Analysis - The Fund invested in Revvity, Inc. due to its potential in the health sciences sector but faced challenges due to management decisions [3] - The overall return on the investment in Revvity, Inc. was -28.5%, with a -5.90% IRR [3] - Revvity, Inc. is not among the 40 Most Popular Stocks Among Hedge Funds, with 35 hedge fund portfolios holding it at the end of Q4, up from 22 in the previous quarter [4] Group 5: Comparative Investment Potential - The firm believes certain AI stocks offer greater upside potential and carry less downside risk compared to Revvity, Inc. [4] - A report on undervalued AI stocks that could benefit from Trump-era tariffs and the onshoring trend is available [4]

Company Overview - Revvity, Inc. (RVTY) is a leading provider of health sciences solutions, technologies, and diagnostic services, headquartered in Waltham, Massachusetts, with a market cap of $10.3 billion [1] Stock Performance - RVTY shares have underperformed the broader market, declining 15% over the past year, while the S&P 500 Index has increased by nearly 12.3% [2] - In 2025, RVTY's stock fell 16.6%, contrasting with the S&P 500's 12.5% rise on a year-to-date basis [2] - Compared to the Health Care Select Sector SPDR Fund (XLV), which gained about 7.5% year-to-date, RVTY's performance has been notably weaker [3] Financial Results - For Q3, RVTY reported revenue of $7 billion, reflecting a year-over-year increase of 2.2%, while adjusted EPS fell 7.8% to $1.18 [4] - Analysts project RVTY's EPS to grow marginally to $4.92 on a diluted basis for the current fiscal year ending in December [4] - RVTY has a strong earnings surprise history, beating consensus estimates in each of the last four quarters [4] Analyst Ratings - Among 17 analysts covering RVTY, the consensus rating is a "Moderate Buy," consisting of nine "Strong Buy" ratings, one "Moderate Buy," and seven "Holds" [5] - Brandon Couillard from Wells Fargo maintained a "Hold" rating with a price target of $102, indicating a potential upside of 9.6% from current levels [6] - The mean price target of $113.07 suggests a 21.5% premium to RVTY's current price, while the highest price target of $135 indicates a potential upside of 45.1% [6]